Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Monique Cohen

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
BMC Surgery|November 17, 2016
Exclusive intraoperative radiotherapy for invasive breast cancer in elderly patients (>70 years): proportion of eligible patients and local recurrence-free survivalEric Lambaudie, Gilles Houvenaeghel, Amira Ziouèche, et al.
Breast (Edinburgh, Scotland)|August 2, 2016
Breast cancer in young women: Pathologic features and molecular phenotypeLaura Sabiani, Gilles Houvenaeghel, Mellie Heinemann, et al.
BMC Cancer|January 12, 2019
Lymph node positivity in different early breast carcinoma phenotypes: a predictive modelGilles Houvenaeghel, Eric Lambaudie, Jean-Marc Classe, et al.
Cancers|October 14, 2020
External Validation of the SERC Trial Population: Comparison with the Multicenter French Cohort, the Swedish and SENOMIC Trial Populations for Breast Cancer Patients with Sentinel Node Micro-MetastasisGilles Houvenaeghel, Houssein El Hajj, Julien Barrou, et al.
European Journal of Cancer (Oxford, England : 1990)|October 4, 2022
Contribution of endocrine therapy in oestrogen receptor-positive pT1a-b breast cancer: Results of a retrospective studyGilles Houvenaeghel, Alexandre de Nonneville, Monique Cohen, et al.
Breast Cancer Research and Treatment|February 14, 2019
Adjuvant chemotherapy in lobular carcinoma of the breast: a clinicopathological score identifies high-risk patient with survival benefitAlexandre de Nonneville, Camille Jauffret, Anthony Gonçalves, et al.
European Journal of Cancer (Oxford, England : 1990)|March 14, 2016
Survival impact and predictive factors of axillary recurrence after sentinel biopsyGilles Houvenaeghel, Jean Marc Classe, Jean-Rémy Garbay, et al.
Breast (Edinburgh, Scotland)|May 6, 2017
Therapeutic escalation - De-escalation: Data from 15.508 early breast cancer treated with upfront surgery and sentinel lymph node biopsy (SLNB)Gilles Houvenaeghel, Eric Lambaudie, Monique Cohen, et al.
Cancer Medicine|September 21, 2022
The need to tailor the omission of axillary lymph node dissection to patients with good prognosis and sentinel node micro-metastasesGilles Houvenaeghel, Alexandre de Nonneville, Nicolas Chopin, et al.
Cancers|March 28, 2024
Does Breast Surgery Type Alter Incidental Axillary Irradiation? A Dosimetric Analysis of the "Sentinel Envahi et Randomisation du Curage" SERC TrialCamille Nicolas, Claire Petit, Agnès Tallet, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
BMC Surgery|November 17, 2016
Exclusive intraoperative radiotherapy for invasive breast cancer in elderly patients (>70 years): proportion of eligible patients and local recurrence-free survivalEric Lambaudie, Gilles Houvenaeghel, Amira Ziouèche, et al.
Breast (Edinburgh, Scotland)|August 2, 2016
Breast cancer in young women: Pathologic features and molecular phenotypeLaura Sabiani, Gilles Houvenaeghel, Mellie Heinemann, et al.
BMC Cancer|January 12, 2019
Lymph node positivity in different early breast carcinoma phenotypes: a predictive modelGilles Houvenaeghel, Eric Lambaudie, Jean-Marc Classe, et al.
Cancers|October 14, 2020
External Validation of the SERC Trial Population: Comparison with the Multicenter French Cohort, the Swedish and SENOMIC Trial Populations for Breast Cancer Patients with Sentinel Node Micro-MetastasisGilles Houvenaeghel, Houssein El Hajj, Julien Barrou, et al.
European Journal of Cancer (Oxford, England : 1990)|October 4, 2022
Contribution of endocrine therapy in oestrogen receptor-positive pT1a-b breast cancer: Results of a retrospective studyGilles Houvenaeghel, Alexandre de Nonneville, Monique Cohen, et al.
Breast Cancer Research and Treatment|February 14, 2019
Adjuvant chemotherapy in lobular carcinoma of the breast: a clinicopathological score identifies high-risk patient with survival benefitAlexandre de Nonneville, Camille Jauffret, Anthony Gonçalves, et al.
European Journal of Cancer (Oxford, England : 1990)|March 14, 2016
Survival impact and predictive factors of axillary recurrence after sentinel biopsyGilles Houvenaeghel, Jean Marc Classe, Jean-Rémy Garbay, et al.
Breast (Edinburgh, Scotland)|May 6, 2017
Therapeutic escalation - De-escalation: Data from 15.508 early breast cancer treated with upfront surgery and sentinel lymph node biopsy (SLNB)Gilles Houvenaeghel, Eric Lambaudie, Monique Cohen, et al.
Cancer Medicine|September 21, 2022
The need to tailor the omission of axillary lymph node dissection to patients with good prognosis and sentinel node micro-metastasesGilles Houvenaeghel, Alexandre de Nonneville, Nicolas Chopin, et al.
Cancers|March 28, 2024
Does Breast Surgery Type Alter Incidental Axillary Irradiation? A Dosimetric Analysis of the "Sentinel Envahi et Randomisation du Curage" SERC TrialCamille Nicolas, Claire Petit, Agnès Tallet, et al.
Pageof 6